Non-motor signs and symptoms in Parkinson’s disease

Motor symptoms are cardinal clinical features of Parkinson’s disease (PD). Progress in drug therapy and rehabilitation has been presenting beneficial effect for motor symptoms. However, non-motor symptoms and signs in PD have been accumulated growing attentions and its amelioration may also give beneficial effect for PD patients’ and their care givers’ quality of life. In this mini-review, I overviewed non-motor symptoms and signs in PD.

Monoamine Oxidase-B Inhibitor Rasagiline Effects on Motor and Non-Motor Symptoms in Individuals with Parkinson’s Disease: A Systematic Review and Meta-Analysis

Objective: In the manuscript titled Monoamine Oxidase-B Inhibitor Rasagiline Effects on Motor and Non-Motor Symptoms in Individuals with Parkinsons Disease: A Systematic Review and Meta-Analysis, the objective was to conduct a systematic review with meta-analysis to investigate the effects that Rasagiline has on motor and non-motor symptoms in individuals with PD. Introduction: Rasagiline is a second-generation monoamine oxidase-B (MAO-B) inhibitor used both as monotherapy and adjunctive therapy for Parkinsons Disease (PD). Methods: A systematic literature search and meta-analysis were performed with randomized control trials that investigated the effects of Rasagiline on motor and non-motor symptoms in individuals with PD. The systematic search was conducted in PubMed, Cochrane, and EBSCO databases. Methodological quality was assessed using the Cochrane Grading Recommendations Assessment, Development and Evaluation approach. Results: Fourteen studies were included in our review. There were trivial to small and statistically significant improvements in motor symptoms for individuals with PD treated with Rasagiline compared to placebo. Non-motor symptoms showed no significant improvement with Rasagiline compared to placebo in five of six meta-analyses. Results were based on very low to moderate certainty of evidence. Conclusion: 1 mg/day Rasagiline significantly improved Parkinsonian motor symptoms in individuals with PD compared with placebo. For all outcomes, the 1 mg/day Rasagiline group was favored over the placebo group.

Effects of a Cocktail Supplement of Ginkgo Biloba and Acai Extract on Cognitive Symptoms of Parkinson’s Disease

Parkinson’s Disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms, including cognitive impairment. Current treatments often involve synthetic drugs with significant side effects and potential for dependency. This study investigates the effects of a natural supplement combination of Ginkgo Biloba and Acai Extract on cognitive symptoms in a 77-year-old male with PD. The participant underwent a three-month supplementation regimen, with cognitive function assessed using the Montreal Cognitive Assessment (MoCA) test before and after the intervention. The results indicated an improvement in cognitive scores, suggesting that the combination of Ginkgo Biloba and Acai Extract may offer a promising alternative or adjunct to conventional PD treatments. This study highlights the potential of natural supplements in managing PD symptoms and calls for further research with larger sample sizes to confirm these findings. Human data was performed in accordance with the Declaration of Helsinki by the Roxbury District IRB Board (IRB Number: IRB00011767).

Symptoms and signs of acute alcoholic hepatitis

Although there is not one specific sign or symptom related to alcoholic hepatitis(AH),a constellation of symptoms and signs can help make the diagnosis of AH with reasonable accuracy.Documentation of chronic and active alcohol abuse is paramount in making a diagnosis of AH.Clinical presentation after abstinence for more than 3 m should raise doubts about the diagnosis of AH and dictate the need for considering other causes of liver disease,decompensation of alcoholic cirrhosis,sepsis and malignancy as the cause of patient's clinical profile.

ACUPUNCTURE TREATMENT OF 40 CASES OF SEVERE HICCUP BASED ON DIFFERENTIATION OF SYMPTOMS AND SIGNS

In the present study, the authors selected points according to differentiation of symptoms and signs and applied filiform needles to treating 40 cases of hiccup who had tried treatment with Western and Chinese drugs but without any effect and achieved satisfactory results. After acupuncture treatment, 34 cases (85 %) were cured, 4 (10 %) improved markedly and 2(5 %) improved, with total effective rate of 100 %.

Oral and peri-oral signs and symptoms of herbal dentifrices in patients in two oral medicine clinics in Lagos—A preliminary study

Background: Herbal dentifrices appear to have become an attractive alternative for some consumers and its use has gained appreciable acceptance in Nigeria. This could be partly due to the perception that herbal toothpastes like other herbal products are “natural”, devoid of chemicals and therefore superior to regular toothpastes. Aggressive advertisement of the products may also contribute to this new trend. Mucosal symptoms such as glossitis and intolerance to spicy foods seen in patients attending the oral diagnosis clinic are usually associated with anaemia and nutritional deficiency states. The disturbing trend of an increasing number of patients presenting with such oral mucosal symptoms associated with the use of herbal dentifrices prompted this study. This trend was observed in two isolated oral medicine clinics. Objective: To sensitize oral health, allied professionals and consumers on the possible adverse effects of regular use of some herbal dentifrices sold in Nigeria. Materials and Methods: Routine patients of two oral medicine clinics in Lagos, namely the Randle General Hospital and the Lagos University Teaching Hospital who complained of some adverse mucosal signs and symptoms following the regular use of two identified herbal toothpastes made up the study population. The study was conducted between April 2010-April 2011. A detailed history and examination was carried out on these patients and clinical photographs of oral signs observed was taken in consenting patients. Data analysis was done using the Epi-info 6 software. P values ≤ 0.05 was considered statistically significant and data was presented in table format. Results: A total of 45 patients, 9 (20%) males and 36 (80%) fe-males were seen. The age range of patients was 14 - 78 years;mean age 45.5 ± 14.9 years. The duration of use of herbal dentifrices ranged from 2 weeks - 84 months (mean 24 ± 11.5 months). Oral signs and symptoms seen include, burning mouth and peppery sensation, mucosal erythema, lichenoid reaction, xerostomia, loss of taste sensation, angio-oedema and oral and peri-oral pigmentation. In many patients, resolution of symptoms was progressive within 2 weeks of withdrawal of the herbal toothpaste and its replacement with a conventional fluoride toothpaste. Most of the patients however required further treatment. A statistically significant association was found between the use of the identified herbal dentifrices and the following mucosal signs and symptoms namely, burning mouth and peppery sensation ,loss of taste sensation, soreness, erythema and lichenoid straie (p value ≤ 0.05). There was no statistically significant association between the use of herbal toothpaste and mucosal signs and symptoms of xerostomia, angular cheilitis, mucosal itching, angio-oedema and numbness (p value > 0.0.5) Conclusion: The regular use of the herbal dentifrices identified in this study can result in oral signs and symptoms affecting taste , nutrition, aesthetics and general oral physiology in some consumers. These findings suggest that further long term clinical trials need to be conducted on the herbal dentifrices to identify the noxious agents causing these symptoms. The formulation and use of these dentifrices need to be standardized and regulated. There is also a need to formulate a treatment protocol for these patients.

Non-Motor Symptoms in Parkinson’s Disease Patients—An Observational Study

Background: Parkinson’s disease (PD) remains a challenge for neurologists, particularly in its advanced stages when non-motor symptoms become a burden for the patient. While motor symptoms may be satisfactorily controlled with levodopa therapy or continuous levodopa/carbidopa intestinal gel (LCIG) administration, autonomic, sleep and mental disorders are hard to treat. During the last years, researchers have shifted their interest more to non-motor symptoms, PD being now considered a complex multiorgan impairment. Objective: The aim of this study was to describe non-motor symptoms in 40 Romanian patients diagnosed with PD, under conventional and LCIG administration treatment. Methods: A cross-sectional observational study was conducted, consisting of two groups of 20 patients each: the first group comprised PD patients who received conventional Levodopa treatment, while the second group was formed of patients receiving LCIG therapy. Various data concerning patient’s age, gender, duration of illness, comorbidities, motor and non-motor symptoms were recorded. The data were processed in SPSS v.20. Results: Subjects under continuous LCIG administration, although showing amelioration of motor symptoms, complained more frequently of constipation, mental, and sleeping disorders (statistically significant). Regarding anosmia, orthostatic hypotension, hypersalivation, urinary incontinence and restless legs syndrome, no statistical significant difference was observed between the two groups (p > 0.05). Conclusion: Nowadays, more research is conducted on non-motor symptoms in PD patients, as therapeutic measures try to limit these burdens, in order to improve patient’s quality of life.

Genetic factors associated with non-motor symptoms in Parkinson’s disease

Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease. It is a complex syndrome with heterogeneous aetiologies, pathogenesis and manifestations. Patients with PD may present with motor symptoms and various non-motor symptoms (NMSs). NMSs have been reported in almost every diagnosed case of PD and usually precede motor symptoms. Multiple factors have been proved to be associated with the occurrence of NMSs in PD, among which genetic differentiation is a featured one. With the development of sequencing techniques, an increasing number of NMS-related genetic factors have been identified. This article reviews some of the latest discoveries in this regard.

Signs and syndromes in acute appendicitis:A pathophysiologic approach

Physical examination signs have not been well studied,and their accuracy and reliability in diagnosis remain unknown.The few studies available are limited in that the method of performing the sign was not stated,the technique used was not standardized,and the position of the appendix was not correlated with imaging or surgical findings.Some appendiceal signs were written in a non-English language and may not have been appropriately translated(e.g.,Blumberg-Shchetkin and Rovsing).In other cases,the sign described differs from the original report(e.g.,Rovsing,Blumberg-Shchetkin,and Cope sign,Murphy syndrome).Because of these studies limitations,gaps remain regarding the signs’utility in the bedside diagnosis of acute appendicitis.Based on the few studies available with these limitations in mind,the results suggest that a positive test is more likely to be found in acute appendicitis.However,a negative test does not exclude the diagnosis.Hence,these tests increase the likelihood of ruling in acute appendicitis when positive but are less helpful in ruling out disease when negative.Knowledge about the correct method of performing the sign may be a valuable adjunct to the surgeon in further increasing their pretest probability of disease.Furthermore,it may allow surgeons to study these signs further to better understand their role in clinical practice.In the interim,these signs should continue to be used as a tool to supplement the clinical diagnosis.

不同类型剖宫产瘢痕妊娠的病例特点与诊治分析

背景现行剖宫产瘢痕妊娠(CSP)分型依据仅参照超声影像特点,目前尚缺乏该分型标准下不同类型CSP病例临床特点的分析总结。目的探讨不同类型CSP的病例特点及诊治差异。方法纳入北京大学第三医院妇产科2014年7月—2022年6月收治的CSP患者共862例为研究对象,根据超声分型标准分为Ⅰ型、Ⅱ型、Ⅲ型组,并对其临床特点及诊治指标进行回顾性分析。结果本研究CSP患者中Ⅰ型组占36.5%(315/862),Ⅱ型组占53.1%(458/862),Ⅲ型组占10.3%(89/862)。3组患者的年龄、孕产史、既往宫腔手术史比例比较,差异均无统计学意义(P>0.05)。CSP患者中腹痛发生率为24.2%(209/862),阴道出血发生率为65.0%(560/862)。3组CSP患者腹痛及阴道出血发生率比较,差异均无统计学意义(P=0.261、0.062)。Ⅲ型组患者诊断时停经时间为55(46,64)d,妊娠物中位径线长29.6(19.1,43.3)mm,术前血β-人绒毛膜促性腺激素(β-HCG)水平为60673(17164,122203)mU/mL,需辅助药物杀胚治疗、腹腔镜监视下手术、子宫动脉阻断率分别为27.0%(24/89)、33.7%(30/89)、32.6%(29/89),手术时长101(67,125)min,住院时间4(3,7)d,治疗花费11933.7(8760.7,15250.6)元,术后24 h累计出血量、出血≥200 mL发生率及输血率分别为83(33,178)mL、24.7%(22/89)、7.9%(7/89),均高于其他两组(P<0.001)。所有患者持续性CSP发生率为3.1%(27/862),3组持续性CSP发生率比较,差异无统计学意义(χ^(2)=3.353,P=0.187)。结论不同类型CSP患者的年龄、孕产史、既往宫腔手术史及腹痛、阴道出血等临床特点无明显差异。Ⅰ型和Ⅱ型患者治疗侵入性较小,Ⅲ型患者的医疗资源消耗较多,对多学科团队及个体化管理有较高要求。不同类型患者经规范管理,其治疗预后均较理想。

腰痛活血胶囊对强直性脊柱炎患者M1、M2型炎症因子的影响

目的探讨腰痛活血胶囊对强直性脊柱炎(AS)患者疗效及M1、M2型炎症因子的影响。方法选取2020年1月至2023年11月安徽中医药大学第一附属医院风湿科收治的60例AS患者,采用随机数字表法分为研究组、对照组各30例。研究组予腰痛活血胶囊(1.2 g,3次/d)联合沙利度胺口服(50 mg,每晚1次),对照组予沙利度胺口服(50 mg,每晚1次),2组均治疗4周。观察治疗前后疼痛视觉模拟评分法(VAS)评分、强直性脊柱炎疾病活动指数(BASDAI)评分、Bath强直性脊柱炎功能指数(BASFI)评分、Bath强直性脊柱炎计量学指数(BASMI)、Bath强直性脊柱炎总体指数(BAS-G)、中医临床证候积分及血清红细胞沉降率(ESR)、C反应蛋白(CRP)、M1型炎症细胞因子[肿瘤坏死因子(TNF)-α、白细胞介素(IL)-6]、M2型炎症细胞因子(IL-4、IL-10)的表达。结果2组治疗后,研究组和对照组的总有效率分别为90%及70%,研究组总有效率高于对照组,差异有统计学意义(P<0.05)。与治疗前相比较,研究组治疗后VAS、BASDAI、BASFI、BAS-G、BASMI、ESR、CRP、TNF-α、IL-6降低,腰骶脊背僵痛积分、腰脊活动受限积分、晨僵积分、夜间疼痛积分、关节肿痛积分及中医证候总积分降低,IL-4、IL-10表达升高(P<0.01)。与对照组治疗后相比较,研究组治疗后VAS、BASDAI、BASFI、CRP、IL-6、腰骶脊背僵痛、腰脊活动受限、夜间疼痛、中医证候总积分降低,IL-10表达升高(P<0.01)。结论腰痛活血胶囊联合沙利度胺可显著改善AS患者临床症状,通过上调M2型炎症因子表达,降低AS患者免疫炎症水平,改善患者临床症状且临床疗效安全。

消化道颗粒细胞瘤临床特征分析

目的分析消化道颗粒细胞瘤(GCT)的临床特征,提高对消化道GCT的认识及其临床诊治水平。方法回顾性分析经病理确诊为消化道GCT病人22例的临床资料。结果22例病人中男17例,女5例,平均年龄(49.36±8.45)岁;发病部位为食管17例(77.27%),回盲部2例(9.09%),结肠3例(13.64%)。17例病人表现为非特异性消化道症状,内镜下病灶最大径0.29~2.00 cm。22例行CT检查,6例食管壁略增厚,1例盲肠壁略增厚,余15例未见明显异常。1例行PET-CT检查,食管下段轻度增厚,结节状代谢增高,SUVmax约2.1。22例行内镜检查,病灶黄色15例(68.18%),白色7例(31.82%)。13例行超声内镜(EUS)检查,病变起源于黏膜下层7例(53.84%),黏膜肌层5例(38.46%),固有肌层1例(7.70%);病变低回声12例(92.30%),低回声混有少量高回声改变1例(7.70%),回声均匀10例(76.92%),回声欠均匀3例(23.08%)。免疫组化检查显示,所有病灶均表达S100,部分表达CD68、SOX10、Ki-67、SDHB、CD34。20例行内镜下治疗,1例行手术治疗,1例随访。病人随访7~69个月,中位随访时间为23个月,除1例病人化疗后失访,余均未见肿瘤复发及转移。结论消化道GCT以男性为主,临床症状无特异性,内镜、EUS检查相结合可提高对其诊断率,确诊需依据病理学及免疫组化检查,内镜下治疗是安全有效的方法。

17例耳硬化症患者的临床与影像学分析

目的分析17例耳硬化症患者的临床特征、影像学表现及手术治疗效果。方法收集2020年5月~2023年5月在湖州市中心医院接受手术治疗的17例(17耳)耳硬化症患者临床、影像学资料,分析其临床表现、颞骨CT影像学表现及手术前后纯音测听结果变化。结果17例(17耳)患者中,11耳(64.71%)为前庭窗型,表现为进行性传导性听力损失,其中9耳有耳鸣,3耳有轻微平衡问题;混合型6耳(35.29%)显示混合性听力损失,5耳有耳鸣,3耳有偶发性平衡障碍。影像学上,前庭窗型显示镫骨底板区域骨质增厚、前庭窗密度增加;混合型则显示镫骨底板增厚及耳蜗周围密度减低,1耳可见“双环征”,两种类型耳硬化症患者骨密度差异无统计学意义(P>0.05)。术后均未见耳鸣加重或其他严重并发症,仅2例(11.76%)出现暂时性头晕,术后随访显示术区恢复良好,无感染或其他迟发性并发症;术后听力测试显示气导阈值、气骨导差较术前显著改善(P均<0.05)。结论前庭窗型和混合型耳硬化症的影像学和临床表现各有特点,镫骨成形术可显著改善听力,降低气导阈值和气骨导差,且手术安全、并发症少。

三伏天联合三九天中药穴位敷贴治疗儿童肺气虚寒型常年性变应性鼻炎临床研究

目的探讨三伏天联合三九天中药穴位敷贴治疗儿童肺气虚寒型变应性鼻炎的临床疗效。方法选择选取2021年1月至2022年12月就诊的90例肺气虚寒型儿童变应性鼻炎患者,随机分为敷贴组、药物组和安慰组,每组30例。比较三组治疗前后的鼻部症状评分、鼻腔体征评分及总有效率。结果敷贴组鼻部症状、鼻腔体征评分均下降,且优于药物组及安慰组(P<0.05),敷贴组中医疗效总有效率显著高于药物组和安慰组(P<0.05)。结论三伏天联合三九天中药穴位敷贴可显著改善儿童肺气虚寒型变应性鼻炎症状,提高临床疗效,值得临床推广应用。

针灸治疗膝关节骨关节炎患者的临床观察

目的:探究膝关节骨关节炎患者应用针灸治疗对NRS、症状体征积分及疗效和安全性影响。方法:选取膝关节骨关节炎患者136例,采用随机数字表法分为对照组和观察组。对照组口服硫酸氨基葡萄糖胶囊治疗;观察组给予针灸治疗;对比两组治疗前和治疗1个月后疼痛程度、生活质量、炎症因子指标和不良反应变化;分析患者膝关节疼痛变化与膝关节功能的相关性。结果:治疗1个月,两组疼痛评分均降低,且观察组明显低于对照组(P<0.05);治疗1个月后,两组患者在疼痛程度、炎症因子、Lysholm评分和WOMAC评分均改善,且观察组改善程度显著更优(P<0.05);两组不良反应无明显差异(P>0.05);pearson相关性分析,结果显示二者呈现显著负相关(r=-0.940,P<0.001)。结论:对膝关节骨关节炎患者应用针灸治疗,可明显改善患者的NRS疼痛评分,改善患者的膝关节功能,提升患者临床治疗效果,且不会增加不良反应的发生风险,临床安全性较高。

抗黑色素瘤分化相关基因5抗体阳性的皮肌炎诊疗进展

抗黑色素瘤分化相关基因5(MDA5)抗体阳性的皮肌炎是皮肌炎的一种亚型,该类患者易出现间质性肺病,特别是快速进展的间质性肺病(RPILD),发生RPILD后,常对激素和免疫抑制剂治疗产生抵抗,尽管积极治疗,死亡率仍高达70%,严重危害患者生命安全。该文阐述了抗MDA5阳性皮肌炎发病机制、临床特征和治疗进展,还重点介绍了抗MDA5阳性皮肌炎RPILD早期识别和预警方法。

加速康复外科在低温等离子下扁桃体切除患者中的护理效果

目的探究加速康复外科在低温等离子下扁桃体切除患者中的护理效果。方法选取2021年1—12月于丰城市人民医院行低温等离子下扁桃体切除术的40例患者作为研究对象,以入院日期单双号为标准分为对照组与观察组,每组20例。对照组采用常规护理,观察组采用加速康复外科护理,比较两组术期相关指标、疼痛程度、临床症状消失时间、手术相关并发症。结果观察组术后正常进食时间、白膜形成时间、白膜脱落时间、住院时间均短于对照组,差异有统计学意义(P<0.05)。术后1、3、5、7d,观察组视觉模拟评分法(visual analogue scale,VAS)评分均低于对照组,差异有统计学意义(P<0.05)。观察组术后睡眠呼吸粗重、鼻翼煽动、流鼻涕、鼻塞症状消失时间均短于对照组,差异有统计学意义(P<0.05)。观察组手术相关并发症发生率为5.00%,低于对照组的30.00%,差异有统计学意义(P<0.05)。结论加速康复外科理念对低温等离子下扁桃体切除护理效果显著,能减轻患者术后疼痛,提高术后舒适度,缩短住院时间,值得临床推广应用。

布地奈德联合乙酰半胱氨酸雾化对儿童大叶性肺炎临床效果的研究分析

目的探讨布地奈德联合乙酰半胱氨酸对儿童大叶性肺炎的治疗效果。方法选取2021年1月—2022年12月在丰县人民医院治疗的120例大叶性肺炎患儿为研究对象,根据掷硬币法分为研究组及对照组,各60例。研究组采用布地奈德联合乙酰半胱氨酸雾化治疗,对照组采用布地奈德雾化治疗。比较两组患儿肺功能、血清炎症因子、临床症状消失时间。结果治疗后,研究组患儿各项肺功能指标改善情况优于对照组,研究组患儿血清超敏C反应蛋白及降钙素原水平低于对照组,研究组患儿临床症状消失时间较对照组更短,差异有统计学意义(P均<0.05)。结论使用布地奈德联合乙酰半胱氨酸雾化治疗大叶性肺炎,能快速改善肺功能,疗效更佳。

公众上呼吸道感染症状的潜在模式及其对抗生素使用行为的影响研究

背景抗生素滥用导致的耐药问题已成全球重大公共卫生议题,减少公众上呼吸道感染的抗生素不合理使用是我国治理抗生素滥用的重要策略,识别上呼吸道感染疾病病症特点及其对抗生素不合理使用行为的影响有助于临床医生设计更为精准的干预政策。目的定量分析公众上呼吸道感染症状的潜在模式,探究其对抗生素使用行为的影响。方法本研究采用整群随机抽样调查,于2022-07-20—08-02选取重庆市三个县(区)的人群作为调查对象。调查公众上呼吸道感染疾病症状、公众上呼吸道感染抗生素使用行为、公众抗生素使用知识及人口学特征。采用潜在类别分析方法鉴别公众上呼吸道感染疾病症状的潜在模式,采用多因素Logistic回归分析探索不同潜在症状模式对抗生素使用行为的影响。结果815位公众参与本研究。其中,30.06%(245/815)受访者存在无处方从药店购买抗生素,14.72%(120/815)受访者使用过抗生素自我药疗以应对上呼吸道感染。公众抗生素合理使用知识水平较低[(2.3±1.7)分]。上呼吸道感染疾病发病模式方面,潜在类别分析共识别4种症状模式,包括多重症状组93例(11.41%)、全身症状组124例(15.21%)、鼻咽症状组282例(34.60%)和轻微症状组316例(38.77%)。多因素Logistic回归分析结果显示:相较于轻微症状组,鼻咽症状组出现无处方购买抗生素行为的概率更高(OR=1.538,P<0.05),该结果在调整知识与人口学变量后仍显著。除个体疾病症状潜在模式外,年龄和医保类型也对公众无处方抗生素购药行为有影响(P<0.05)。抗生素使用知识水平对抗生素自我药疗行为有影响(OR=0.869,P<0.05),对公众无处方抗生素购药行为也有影响(OR=1.155,P<0.05)。结论公众上呼吸道感染症状存在4种潜在模式,疾病病症模式影响公众抗生素的合理使用,应着重关注出现鼻咽症状患者的抗生素不合理使用行为。

超重人群中健康者与非酒精性脂肪性肝病患者的临床特征及血清脂质组学分析

目的探究超重人群中,非酒精性脂肪性肝病(NAFLD)患者与健康人的临床指标与脂质代谢差异。方法本研究将体质量指数(BMI)>23 kg/m^(2)定义为超重人群,选取2020年8月—2021年4月上海中医药大学附属普陀医院收治的62例超重NAFLD患者纳入超重NAFLD组,另选取同期超重健康体检者50例作为对照。记录所有受试者的临床信息以及血液生化指标数据。应用超高效液相色谱-串联质谱法(UPLC-MS/MS)进行血清脂质组学分析;使用主成分分析法和正交偏最小二乘法判别分析对脂质组学数据进行多元统计分析。计数资料两组间比较采用χ^(2)检验。计量资料两组间比较采用成组t检验或Wilcoxon秩和检验。结果超重NAFLD组BMI显著高于超重对照组(Z=-2.365,P=0.018)。血清学指标中,超重NAFLD组红细胞、血红蛋白、红细胞比容、尿酸、总蛋白、球蛋白、ALP、GGT、ALT、AST、胆碱酯酶、低密度脂蛋白、总胆固醇、甘油三酯、载脂蛋白B、血糖水平均显著高于超重对照组(P值均<0.05)。脂质组学分析结果显示两组间脂质代谢具有明显差异,共鉴定出差异性脂质(VIP值>1,P<0.05)493个,其中超重NAFLD组中有143个脂质显著上调,350个脂质显著下调。超重NAFLD组的平均脂肪酸总量是超重对照组的3.6倍。超重NAFLD组不饱和键数>3的甘油三酯含量较超重对照组降低(P<0.001),而不饱和键数≤3的甘油三酯含量较超重对照组增多(P<0.001)。结论超重NAFLD患者的部分生化指标及脂质代谢产物明显异于超重健康人,血液内脂肪酸明显升高,甘油三酯中的含饱和脂肪链的种类显著升高。